Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Guglielmetti

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Pathogens (Basel, Switzerland)|October 27, 2022
Preventive Therapy for Contacts of Drug-Resistant TuberculosisYousra Kherabi, Simone Tunesi, Alexander Kay, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 15, 2024
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in EuropeGunar Günther, Lorenzo Guglielmetti, Yousra Kherabi, et al.
La Revue Du Praticien|March 29, 2024
[Advances in antibiotic therapy for tuberculosis]Thomas Maitre, Lorenzo Guglielmetti, Jérôme Robert, et al.
Future Microbiology|September 8, 2015
Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of viewLorenzo Guglielmetti, Faiza Mougari, Amanda Lopes, et al.
Le Infezioni in Medicina|June 19, 2013
[Pulmonary tuberculosis mimicking a severe community-acquired pneumonia with rhabdomyolysis]Andrea Tedesco, Lorenzo Guglielmetti, Michela Conti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 12, 2022
Availability and costs of medicines for the treatment of tuberculosis in EuropeGunar Günther, Lorenzo Guglielmetti, Claude Leu, et al.
Le Infezioni in Medicina|April 6, 2012
[Diagnostic sensitivity of QuantiFERON-TB Gold In-Tube and tuberculin skin test in active tuberculosis: influence of immunocompromission and radiological extent of disease]Lorenzo Guglielmetti, Michela Conti, Angelo Cazzadori, et al.
Expert Review of Anti-Infective Therapy|October 4, 2016
Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatmentFaiza Mougari, Lorenzo Guglielmetti, Laurent Raskine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2022
Efficacy and Tolerability of Concomitant Use of Bedaquiline and Delamanid for Multidrug- and Extensively Drug-Resistant Tuberculosis: A Systematic Review and Meta-AnalysisFreja Breth Holmgaard, Lorenzo Guglielmetti, Troels Lillebaek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Poor Performance of Rapid Molecular Tests to Define Eligibility for the Shortcourse Multidrug-resistant Tuberculosis RegimenLorenzo Guglielmetti, Wladimir Sougakoff, Thomas Maitre, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Pathogens (Basel, Switzerland)|October 27, 2022
Preventive Therapy for Contacts of Drug-Resistant TuberculosisYousra Kherabi, Simone Tunesi, Alexander Kay, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 15, 2024
Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in EuropeGunar Günther, Lorenzo Guglielmetti, Yousra Kherabi, et al.
La Revue Du Praticien|March 29, 2024
[Advances in antibiotic therapy for tuberculosis]Thomas Maitre, Lorenzo Guglielmetti, Jérôme Robert, et al.
Future Microbiology|September 8, 2015
Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of viewLorenzo Guglielmetti, Faiza Mougari, Amanda Lopes, et al.
Le Infezioni in Medicina|June 19, 2013
[Pulmonary tuberculosis mimicking a severe community-acquired pneumonia with rhabdomyolysis]Andrea Tedesco, Lorenzo Guglielmetti, Michela Conti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 12, 2022
Availability and costs of medicines for the treatment of tuberculosis in EuropeGunar Günther, Lorenzo Guglielmetti, Claude Leu, et al.
Le Infezioni in Medicina|April 6, 2012
[Diagnostic sensitivity of QuantiFERON-TB Gold In-Tube and tuberculin skin test in active tuberculosis: influence of immunocompromission and radiological extent of disease]Lorenzo Guglielmetti, Michela Conti, Angelo Cazzadori, et al.
Expert Review of Anti-Infective Therapy|October 4, 2016
Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatmentFaiza Mougari, Lorenzo Guglielmetti, Laurent Raskine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2022
Efficacy and Tolerability of Concomitant Use of Bedaquiline and Delamanid for Multidrug- and Extensively Drug-Resistant Tuberculosis: A Systematic Review and Meta-AnalysisFreja Breth Holmgaard, Lorenzo Guglielmetti, Troels Lillebaek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2018
Poor Performance of Rapid Molecular Tests to Define Eligibility for the Shortcourse Multidrug-resistant Tuberculosis RegimenLorenzo Guglielmetti, Wladimir Sougakoff, Thomas Maitre, et al.
Pageof 6